FDA Investigator: Debra M. Emerson
- Debra M. Emerson first started conducting FDA inspections in 2002, with the last inspection in 2022. Over that time, Debra M. Emerson has conducted 228 inspections at 180 companies across 191 sites.
Documents
FDA 483 CSL Behring L.L.C, Bradley | September 2021
Available - $199
Debra M. Emerson
Biologic Form 483
FDA 483 Wyeth BioPharma Division of Wyeth Pharmaceuti | 2021
Available - $199
Debra M. Emerson
Biologic Form 483
FDA 483 Emergent Manufacturing Operations Baltimore | 2021
Available - $199
Debra M. Emerson
Biologic Form 483
FDA 483 Genzyme Polyclonals S, Lyon | February 2020
Available - $199
Debra M. Emerson
Biologic Form 483
FDA 483 Wyeth BioPharma Division of Wyeth Pharmaceuti | 2017
Available - $199
Debra M. Emerson
Biologic Form 483
FDA 483 Jubilant HollisterStier, Spokane | December 2014
Available - $199
Debra M. Emerson
Biologic Form 483
FDA 483 Glaxo Smithkline - Rixensart, Rixensart | Oct 2014
Available - $199
Debra M. Emerson
Biologic Form 483
FDA 483 Village Fertility Pharmacy, Waltham | March 2013
Available - $199
Debra M. Emerson
Human Drug Form 483
FDA 483 Central Admixture Pharmacy Services, Woburn | 2013
Available - $199
Debra M. Emerson
Human Drug Form 483
FDA 483 Alaunus Pharmaceutical, Framingham | November 2012
Available - $199
Debra M. Emerson
Human Drug Form 483
FDA 483 ID Biomedical Corporation of Quebec, Quebec | 2022
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 Emergent BioSolutions Canada Inc., Winnipeg | 2022
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 LFB USA, Inc., Charlton | 2022
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 CSL Behring GmbH, Marburg | 2022
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 Catalent Maryland, Inc., Harmans | 2021
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 Lonza Biologics, Inc., Portsmouth | 2021
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 Therapure Biopharma Inc, Mississauga | 2020
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 Rentschler Biopharma Inc., Milford | 2019
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 MassBiologics, Boston | 2019
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 Biovex Incorporated, Woburn | 2019
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 GlaxoSmithKline Biologicals SA, Rixensart | 2019
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 Charles River Laboratories, Inc. DBA Charles River, Endosafe, Charleston | 2019
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 Octapharma Pharmazeutika Produktionsges.m.b.H., Vienna | 2019
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 SmartPractice Denmark ApS, Hillerod | 2019
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 Cangene BioPharma, LLC dba Emergent BioSolutions, Rockville | 2019
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 Sanofi Pasteur, Neuville Sur Saone | 2018
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 Sanofi Pasteur, Val De Reuil | 2018
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 Associates of Cape Cod, Inc., East Falmouth | 2018
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 Cangene BioPharma, LLC, Baltimore | 2018
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 AbbVie Bioresearch Center, Inc., Worcester | 2018
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 Ortho-Clinical Diagnostics, Inc., Raritan | 2018
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 OKC Allergy Supplies, Inc., Oklahoma City | 2018
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 Emergent Product Development Gaithersburg, Canton | 2017
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 Novartis Pharma Stein AG, Stein Ag | 2017
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 Baxalta Manufacturing Sarl, Neuchatel | 2017
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 MassBiologics, Boston | 2017
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 Octapharma AB, Stockholm | 2016
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 Pharming Technologies Bv, Leiden | 2016
Out-of-stock
Debra M. Emerson
Human Drug Form 483
FDA 483 Genzyme Polyclonals S.A.S., Lyon | 2016
Out-of-stock
Debra M. Emerson
Biologic Form 483
FDA 483 Sanofi Winthrop Industrie, Le Trait | 2016
Out-of-stock
Debra M. Emerson
Biologic Form 483
Co-Investigators (84)
- Linda Thai, FDA Investigator
- Laurel A. Beer, FDA Investigator
- Prabhu P. Raju, FDA Investigator
- Claire M. Minden, FDA Investigator
- Pankaj H. Amin, FDA Investigator
- Obinna R. Echeozo, FDA Investigator
- Kathleen R. Jones, FDA Investigator
- Anissa M. Cheung, FDA Investigator
- Ekaterina Allen, FDA Investigator
- Cody D. Rickman, FDA Investigator
- Jeremy L. Wally, FDA Investigator
- Alice C. Silva, FDA Investigator
- Eileen A. Liu, FDA Investigator
- Jie He, FDA Investigator
- Janet L. Bowen, FDA Investigator
- Susan M. Jackson, FDA Investigator
- Leslie D. Wagner, FDA Investigator
- Lindsey R. Lyman, FDA Investigator
- Peter S. Kessler, FDA Investigator
- Ze Peng, FDA Investigator
- Shuang Tang, FDA Investigator
- James L. Kenney, FDA Investigator
- Lu Deng, FDA Investigator
- Dino A. Feigelstock, FDA Investigator
- Silvia Wanis, FDA Investigator
- Jacqueline M. Diaz Albert, FDA Investigator
- Diaz Albert, Jacqueline M, FDA Investigator
- Margaret M. Annes, FDA Investigator
- Michele L. Forster, FDA Investigator
- Sean R. Marcsisin, FDA Investigator
- Jonathan G. Matrisciano, FDA Investigator
- Arie Menachem, FDA Investigator
- Cynthia Jim, FDA Investigator
- Mihaly S. Ligmond, FDA Investigator
- Simone E. Pitts, FDA Investigator
- Gene D. Arcy, FDA Investigator
- Rebecca Rodriguez, FDA Investigator
- Heika R. Tait, FDA Investigator
- Omotunde O. Osunsanmi, FDA Investigator
- Jeremy W. Rotton, FDA Investigator
- Mary-Jeanet McGarry, FDA Investigator
- Ramon E. Martinez, FDA Investigator
- Edmund F. Mrak, FDA Investigator
- Thomas J. Arista, FDA Investigator
- Philip Kreiter, FDA Investigator
- Stacey S. Degarmo, FDA Investigator
- Almaris N. Alonso, FDA Investigator
- Thomas W. Nerney, FDA Investigator
- Robert J. Martin, FDA Investigator
- Jose A. Lopez Rubet, FDA Investigator
- Lopez Rubet, Jose A, FDA Investigator
- Megan A. Haggerty, FDA Investigator
- Neal L. Adams, FDA Investigator
- Rory Geyer, FDA Investigator
- Sarah E. McMullen, FDA Investigator
- Justine M. Corson, FDA Consumer Safety Officer
- Leo B. Zadecky, FDA Investigator
- Matthew C. Watson, FDA Investigator
- Douglas Fiorentino, FDA Investigator
- Rochelle L. Cross, FDA Investigator
- Kent A. Conforti, FDA Investigator
- Richard H. Penta, FDA Investigator
- Ellen P. Madigan, FDA Investigator
- Brenda P. King, FDA Investigator
- Elizabeth B. Griffin, FDA Investigator
- Michael J. Casey, FDA Investigator
- Martin J. Guardia, FDA Investigator
- Michelle M. Noe, FDA Investigator
- Christopher K. Vantwuyver, FDA Investigator
- Christopher M. Elliott, FDA Investigator
- Troy R. Petrillo, FDA Investigator
- Paula M. Laplant, FDA Investigator
- Lorayne A. McGuinness, FDA Investigator
- Lori A. Holmquist, FDA Investigator
- Paul P. Geraci, FDA Investigator
- Kristina J. Donohue, FDA Investigator
- Garry H. Stewart, FDA Investigator
- Sherry M. Nisson, FDA Investigator
- Andrew M. Barlow, FDA Investigator
- Louis Christy, FDA Investigator
- Paraluman S. Leonin, FDA Investigator
- Jason A. Rossi, FDA Investigator
- Erin P. Conlin, FDA Investigator
- Gary J. Hagan, FDA Investigator